Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LANV.WS
5001
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
| $10 | ﹤0.01% |
500
| – | – |
2022 Q4
10 quarters
|
|
|
MURA
5002
DELISTED
Mural Oncology
MURA
| $10 | ﹤0.01% |
4
| – | – |
2023 Q4
6 quarters
|
|
|
XMAX
5003
XMAX Inc
XMAX
$554M
| $10 | ﹤0.01% |
7
| – | – |
2022 Q1
13 quarters
|
|
|
RENT
5004
Rent the Runway
RENT
$52.6M
| $10 | ﹤0.01% |
2
| – | – |
2025 Q1
1 quarter
|
|
5005
Star Holdings Shares of Beneficial Interest
STHO
$102M
| $8 | ﹤0.01% |
1
-13,027
| -100% | -$90K |
2023 Q1
9 quarters
|
|
5006
Verrica Pharmaceuticals
VRCA
$75.2M
| $8 | ﹤0.01% |
2
-4,436
| -100% | -$23.9K |
2023 Q1
9 quarters
|
|
5007
Cumberland Pharmaceuticals
CPIX
$111M
| $7 | ﹤0.01% |
+2
| New | +$9 |
2025 Q2
0 quarters
|
|
5008
Momentus
MNTS
$81.5M
| – | – |
0
| – | – |
2023 Q4
6 quarters
|
|
5009
Jasper Therapeutics
JSPR
$18.8M
| $6 | ﹤0.01% |
1
-17,959
| -100% | -$88.4K |
2024 Q2
4 quarters
|
|
|
ONL
5010
Orion Office REIT
ONL
$137M
| $6 | ﹤0.01% |
3
-56,528
| -100% | -$108K |
2022 Q1
13 quarters
|
|
5011
Sera Prognostics
SERA
$82.4M
| $6 | ﹤0.01% |
2
-31,078
| -100% | -$76.9K |
2024 Q2
4 quarters
|
|
|
UHG
5012
DELISTED
United Homes Group
UHG
| $6 | ﹤0.01% |
2
-9,389
| -100% | -$24.4K |
2023 Q2
8 quarters
|
|
|
AGEN
5013
Agenus
AGEN
$378M
| $5 | ﹤0.01% |
1
-26,301
| -100% | -$91.1K |
2014 Q2
44 quarters
|
|
5014
CytomX Therapeutics
CTMX
$558M
| $5 | ﹤0.01% |
2
| – | – |
2025 Q1
1 quarter
|
|
5015
FTC Solar
FTCI
$35.5M
| $5 | ﹤0.01% |
1
| – | – |
2022 Q1
13 quarters
|
|
|
KZR
5016
DELISTED
Kezar Life Sciences
KZR
| $5 | ﹤0.01% |
1
| – | – |
2024 Q4
2 quarters
|
|
5017
INNOVATE Corp
VATE
$102M
| $5 | ﹤0.01% |
1
| – | – |
2023 Q1
9 quarters
|
|
|
BLUE
5018
DELISTED
bluebird bio
BLUE
| $4 | ﹤0.01% |
1
-9,812
| -100% | -$43.9K |
2013 Q3
47 quarters
|
|
5019
Full House Resorts
FLL
$50.9M
| $4 | ﹤0.01% |
1
-34,060
| -100% | -$114K |
2021 Q1
17 quarters
|
|
5020
Odyssey Marine Exploration
OMEX
$39M
| $4 | ﹤0.01% |
3
-54
| -95% | -$49 |
2025 Q1
1 quarter
|
|
5021
Metagenomi Therapeutics
MGX
$38.5M
| $4 | ﹤0.01% |
3
-28,845
| -100% | -$45.2K |
2024 Q2
4 quarters
|
|
|
ASRT
5022
DELISTED
Assertio
ASRT
| – | – |
-291
| Closed | -$2.8K | – |
|
5023
Cibus
CBUS
$131M
| $3 | ﹤0.01% |
2
-18,393
| -100% | -$37.4K |
2024 Q1
5 quarters
|
|
5024
Microbot Medical
MBOT
$77.9M
| $3 | ﹤0.01% |
1
-5
| -83% | -$12 |
2015 Q4
38 quarters
|
|
5025
Swvl Holdings Corp Warrant
SWVLW
$106K
| $3 | ﹤0.01% |
238
| – | – |
2022 Q2
12 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.